• Agreement will ensure digital continuity and improve access and security of diverse workflows and data.
• Project roll-out to 800 users at Arkema’s research sites in France.

Bishop’s Stortford, UK: Dotmatics Ltd, a scientific informatics software and services company that is driving the automation of laboratory data workflows for scientific discovery and innovation research, today announced it has been selected by Arkema, a global leader in speciality materials, as its informatics partner in an R&D digitalization project. Implementing Dotmatics’ unified electronic laboratory notebook (ELN) across Arkema’s research sites in France, the agreement covers 800 users and will run over 5 years.

At a time when the Chemical Industry is transforming R&D through digitalizing laboratory workflows, the agreement supports Arkema’s project to modernize access to R&D data and reduce design times for new products. The objective is to ensure digital continuity of all experimental data, thus allowing for faster innovation of chemicals and materials driven by statistics, calculation and modelling, and artificial intelligence.

Dotmatics will equip Arkema scientists with a complete ELN solution including experiment capture, entity registration and sample tracking, data retrieval, and full data analytics. The unified platform will accommodate the diversity of Arkema’s workflow across synthetic chemistry, formulation and polymers allowing researchers to trace, share, secure and exploit all their R&D data internally and will facilitate collaboration with external partners.

Steve Gallagher, CEO of Dotmatics, commented: “With our shared spirit of collaboration, we are delighted to have been chosen as a partner to implement their R&D digitalization project and we welcome Arkema to the Dotmatics community of global scientific organizations.

Implementing Dotmatics’ ELN will allow Arkema researchers to leverage valuable corporate R&D data. Web-based rapid capture, search and retrieval of data combined with advanced analytics will support global shared decision-making: empowering scientists to innovate.”

Gérard Guilpain, Scientific Director of Digitalization of R&D at Arkema, commented: “The ELN is a fundamental digital building block for processing experimental results generated in our laboratories. We are happy to have selected Dotmatics, which will allow us to modernize our work approaches and use a cloud infrastructure as a space for digital continuity to gain value more rapidly from the Group’s research data.”

 For further information on Dotmatics, please visit www.dotmatics.com

About Dotmatics Ltd. (www.dotmatics.com)
Dotmatics is a scientific informatics software and services company that is driving the automation of laboratory workflows for discovery and innovation research – accelerating the journey towards full digitalization and the Lab of the Future.

With a mission to give scientists access to all of their data, all of the time, Dotmatics provides a unique portfolio of tools for fully automated, end-to-end workflows including data acquisition, knowledge management, data storage, enterprise querying and reporting, and data analytics and visualization. Through these comprehensive solutions, the Company is helping its customers to increase lab efficiency and make better informed decisions driven by all data.

Dotmatics’ customers include many of the world’s leading pharmaceutical, biotechnology, contract research, chemicals and materials companies. Insight into the challenges faced by these organizations enables Dotmatics to focus on delivering versatile and intuitive products and services that have potential to turn around the productivity deficit in research and accelerate development of novel drug candidates or products.

Dotmatics was founded in 2005 by two scientists from Merck Pharmaceuticals (MSD). Since then it has built a strong and profitable business with an expert team of over 200 scientists, software developers and engineers, and project managers. The Company is headquartered in the UK with offices in USA, Korea and Japan and is backed by growth equity firm Scottish Equity Partners, SEP (www.SEP.co.uk).

 About Arkema (www.arkema.com)
Building on its unique set of expertise in materials science, Arkema offers a portfolio of first-class technologies to address ever-growing demand for new and sustainable materials. With the ambition to become in 2024 a pure player in Specialty Materials, the Group is structured into 3 complementary, resilient and highly innovative segments dedicated to Specialty Materials -Adhesive solutions, Advanced Materials, and Coating Solutions- accounting for some 80% of Group sales, and a well-positioned and competitive Intermediates segment. Arkema offers cutting-edge technological solutions to meet the challenges of, inter alia, new energies, access to water, recycling, urbanization and mobility, and fosters a permanent dialogue with all its stakeholders. The Group reported sales of €7.9 billion in 2020, and operates in some 55 countries with 20,600 employees worldwide.